CRC group: 68.4 ± 2.4 Objectives Italy) y Evaluate safety and efficacy of MTA Cooled-shaft antennae Other: 68.6 ± 3.7 y in treating solitary primary and metastatic liver tumours Male/female: not reported by cancer type Percutaneous MTA Yu et al () Case series N = 307 Inclusion Outcomes - 2000, Kangyou Medical, China Level IV Metastases from: Single lesion ≤8 cm Local tumour recurrence Nanjing, China) {Also includes Quality: moderate Gastrointestinal = 387 ≤3 lesions ≤4 cm Statistical analysis 915 and 2450 MHz, 50–60 pop 1 data} Breast = 47 Normal serum total bilirubin Kaplan–Meier analysis W Lung = 44 Normal albumin level Duration of follow-up Cooled antennae Median 20.3 months, range Pancreas = 38 Platelet count >50 × 109/mm3 months Extrahepatic CCA = 37 Prothrombin activity >50% Ovarian = 26 Exclusion Portal vein thrombosis or Other = 74 extrahepatic metastases Male/female not reported for pop 2 Objectives Age not reported for Elucidate incidence of local tumour pop 2 recurrence after percutaneous MTA; evaluate risk factors CCA = cholangiocarcinoma; CRC = colorectal cancer; HCC = hepatocellular carcinoma; MRI = magnetic resonance imaging; MTA = microwave thermal ablation; MTA = microwave tissue ablation; TACE = transcatheter arterial chemoembolisation; RFA = radiofrequency ablation; SD = standard deviation; SPSS = Statistical Package for Social Sciences
CRC group: 68.4 ± 2.4 y Other: 68.6 ± 3.7 y Male/female: not reported by cancer type Objectives Evaluate safety and efficacy of MTA in treating solitary primary and metastatic liver tumours Italy) Cooled-shaft antennae Yu et al () China {Also includes pop 1 data} Case series Level IV Quality: moderate N = 307 Metastases from: Gastrointestinal = 387 Breast = 47 Lung = 44 Pancreas = 38 Extrahepatic CCA = 37 Ovarian = 26 Other = 74 Male/female not reported for pop 2 Age not reported for pop 2 Inclusion Single lesion ≤8 cm ≤3 lesions ≤4 cm Normal serum total bilirubin Normal albumin level Platelet count >50 × 109/mm3 Prothrombin activity >50% Exclusion Portal vein thrombosis or extrahepatic metastases Objectives Elucidate incidence of local tumour recurrence after percutaneous MTA; evaluate risk factors Percutaneous MTA Kangyou Medical, Nanjing, China) 915 and 2450 MHz, 50–60 W Cooled antennae Outcomes Local tumour recurrence Statistical analysis Kaplan–Meier analysis Duration of follow-up Median 20.3 months, range months - CCA = cholangiocarcinoma; CRC = colorectal cancer; HCC = hepatocellular carcinoma; MRI = magnetic resonance imaging; MTA = microwave thermal ablation; MTA = microwave tissue ablation; TACE = transcatheter arterial chemoembolisation; RFA = radiofrequency ablation; SD = standard deviation; SPSS = Statistical Package for Social Sciences 2000,
1402-%20Final%20Contracted%20Assessment%20Report%20(ACCESSIBLE).docx